Does the meningitis b vaccine last? study tests kids 4 years later
NCT ID NCT01565577
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 117 children aged 4-8 who had received four doses of the MenBVac vaccine against meningitis B. Researchers measured how many still had protective antibodies four years after the last dose. The goal was to see if the vaccine's immunity lasts over time.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION WITH MENBVAC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UH-rouen
Rouen, Seine Maritime, 76000, France